These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 8494600

  • 1. Structure-based drug design: inhibitors of purine nucleoside phosphorylase.
    Montgomery JA.
    Farmaco; 1993 Feb; 48(2):297-308. PubMed ID: 8494600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structure-based drug design: inhibitors of purine nucleoside phosphorylase. Index: structure-based drug design: inhibitors of PNP.
    Montgomery JA.
    Drug Des Discov; 1994 Jun; 11(4):289-305. PubMed ID: 7727681
    [No Abstract] [Full Text] [Related]

  • 7. Determining the structural basis for specificity of ligands using crystallographic screening.
    de Azevedo WF, Canduri F, Basso LA, Palma MS, Santos DS.
    Cell Biochem Biophys; 2006 Jun; 44(3):405-11. PubMed ID: 16679527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.
    Farutin V, Masterson L, Andricopulo AD, Cheng J, Riley B, Hakimi R, Frazer JW, Cordes EH.
    J Med Chem; 1999 Jul 01; 42(13):2422-31. PubMed ID: 10395483
    [Abstract] [Full Text] [Related]

  • 13. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW, Tyler PC, Furneaux RH, Bagdassarian CK, Schramm VL.
    Biochemistry; 1998 Jun 16; 37(24):8615-21. PubMed ID: 9628722
    [Abstract] [Full Text] [Related]

  • 14. Structures for the potential drug target purine nucleoside phosphorylase from Schistosoma mansoni causal agent of schistosomiasis.
    Pereira HD, Franco GR, Cleasby A, Garratt RC.
    J Mol Biol; 2005 Oct 28; 353(3):584-99. PubMed ID: 16182308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 A resolution.
    Koellner G, Luić M, Shugar D, Saenger W, Bzowska A.
    J Mol Biol; 1997 Jan 17; 265(2):202-16. PubMed ID: 9020983
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of human PNP complexed with hypoxanthine and sulfate ion.
    Canduri F, Fadel V, Dias MV, Basso LA, Palma MS, Santos DS, de Azevedo WF.
    Biochem Biophys Res Commun; 2005 Jan 14; 326(2):335-8. PubMed ID: 15582582
    [Abstract] [Full Text] [Related]

  • 20. Structures of Plasmodium falciparum purine nucleoside phosphorylase complexed with sulfate and its natural substrate inosine.
    Schnick C, Robien MA, Brzozowski AM, Dodson EJ, Murshudov GN, Anderson L, Luft JR, Mehlin C, Hol WG, Brannigan JA, Wilkinson AJ.
    Acta Crystallogr D Biol Crystallogr; 2005 Sep 14; 61(Pt 9):1245-54. PubMed ID: 16131758
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.